VIEWPOINT | ‘Pill penalty’ flaw threatens healthcare innovation

Guest column by Joni Ekstrum, executive director of the South Dakota Biotech Association

Joni Ekstrum

South Dakota Leaders Can Help Fix a Flaw That Threatens Healthcare Innovation"

Small-molecule medicines, commonly prescribed pills and capsules, make up over 90 percent of prescriptions in the United States. These treatments are essential for managing heart disease, cancer, mental health disorders and countless other conditions. But a harmful provision in the Inflation Reduction Act (IRA) is threatening future innovation in this space, jeopardizing patient access to life-saving medications.

VIEWPOINT | A swipe at small businesses: The hidden dangers of credit card legislation